AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Recent News
-
-
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
-
Myocardial Recovery is Possible After LVAD Implantation for Heart Failure
AdventHealth is the first Florida hospital to join the Myocardial Recovery International Network, a consortium exploring LVAD-mediated myocardial recovery.
-
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
-
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
-
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was... -
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
-
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
-
Forging New Frontiers in Telesurgery to Improve Global Health Access, Outcomes and Equity
In our latest Clinician’s View, Dr. Patel shares his team’s journey toward improving global health access, outcomes and equity through telesurgery, including how they are ensuring the safety, quality...
-
Surgical Resection of Rare Pediatric Desmoid Jaw Tumor Optimizes Outcome and Helps Patient Avoid Chemotherapy
In our latest clinician’s view, Dr. Lopez shares how he, along with a multidisciplinary clinical team, were able to plan for this complex case and completely remove the tumor surgically, allowing...
-
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
-
AdventHealth Participating in Phase I Clinical Trial of Potential New Oral Immunotherapy Treatment for Mild to Moderate Ulcerative Colitis
AdventHealth Research Institute is the first in Central Florida to participate in the expansion phase of a clinical trial exploring a potential new oral immunotherapy treatment for mild to moderate...
-
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...